₹5,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 10 Years
If you had started a ₹5,000/month SIP on 18 Aug 2016 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 121 installments.
You invested
₹6,05,000
121 installments
Value today
₹15,59,045
18 Aug 2026
Absolute gain
+₹9,54,045
+157.7%
XIRR (annualised)
17.97%
money-weighted
The journey, month by month
Worst fall on the way
-19.6%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
4
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹8,42,229
Modelled at historical FD rates. The fund beat FD by ₹7,16,816.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (18 Aug 2017) | ₹65,000 | ₹58,025 | -10.7% |
| Year 2 (20 Aug 2018) | ₹1,25,000 | ₹1,41,926 | +13.5% |
| Year 3 (19 Aug 2019) | ₹1,85,000 | ₹1,81,690 | -1.8% |
| Year 4 (18 Aug 2020) | ₹2,45,000 | ₹3,75,550 | +53.3% |
| Year 5 (18 Aug 2021) | ₹3,05,000 | ₹5,94,987 | +95.1% |
| Year 6 (18 Aug 2022) | ₹3,65,000 | ₹5,97,247 | +63.6% |
| Year 7 (18 Aug 2023) | ₹4,25,000 | ₹8,12,653 | +91.2% |
| Year 8 (19 Aug 2024) | ₹4,85,000 | ₹12,41,685 | +156% |
| Year 9 (18 Aug 2025) | ₹5,45,000 | ₹13,62,822 | +150.1% |
| Year 10 (18 Aug 2026) | ₹6,05,000 | ₹15,59,045 | +157.7% |
Best year of the journey: Year 4 (+55.4% market move) · Toughest year: Year 1 (-10.7%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 18 Aug 2016 and 18 Aug 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.